CONSERVATIVE MANAGEMENT OF PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN ERA: THE INCIDENCE AND TIME COURSE OF SUBSEQUENT THERAPY-Reference-Cited by-同舟云学术

CONSERVATIVE MANAGEMENT OF PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN ERA: THE INCIDENCE AND TIME COURSE OF SUBSEQUENT THERAPY

Published:2001-11 Issue:5 Volume:166 Page:1702-1706
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

ZIETMAN ANTHONY L.¹,THAKRAL HARJOT¹,WILSON LANA¹,SCHELLHAMMER PAUL¹

Affiliation:

1. From the Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, and Department of Urology and Virginia Prostate Center of Sentara Cancer Center Institute and Eastern Virginia Medical School, Norfolk, Virginia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer;Albertsen;JAMA,1998

2. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer;Fowler;JAMA,2000

3. Expectant management and the natural history of localized prostate cancer;Catalona;J Urol part 2,1994

4. If you “watch and wait” prostate cancer may progress dramatically;Allison;Int J Radiat Oncol Biol Phys,1997

5. Results of conservative management of clinically localized prostate cancer;Chodak;N Engl J Med,1994

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical management of prostate cancer;Evidence-Based Urology;2018-07-06

2. In-Bore Magnetic Resonance Imaging-Targeted Prostate Biopsy;Imaging and Focal Therapy of Early Prostate Cancer;2017

3. The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation;Archives of Pathology & Laboratory Medicine;2014-10

4. Quality of Life in Men Undergoing Active Surveillance for Localized Prostate Cancer;JNCI Monographs;2012-12-01

5. Active Surveillance in Men With Localized Prostate Cancer;Annals of Internal Medicine;2012-04-17